血小板におけるトロンビンシグナル伝達が,血液静止と血栓形成における役割
G R Sambrano1, E J Weiss, Y W Zheng
1Cardiovascular Research Institute, University of California, 513 Parnassus Avenue, San Francisco, California 94143-0130, USA.
Nature
|September 7, 2001
まとめ
トロンビンによる血小板活性化は,正常な血液凝固 (血液静止) と動脈血栓形成に不可欠である. PAR4受容体のシグナル伝達は,このトロンビン誘発の血小板応答に不可欠です.
科学分野:
- 血液学 ヘマトロジ
- 分子生物学は分子生物学である.
- 生理学 生理学とは
背景:
- 血小板は,血液静止と動脈血栓形成において重要な役割を果たします.
- トロンビンは,血小板を活性化する重要な凝固プロテアゼです.
- 血静と血栓形成におけるトロンビン誘発の血小板活性化の正確な役割は完全に理解されていません.
研究 の 目的:
- トロンビン誘発の血小板活性化のためのプロテアゼ活性化受容体 (PAR) 信号伝達の必要性を調査する.
- 血静と血栓形成におけるPAR4媒介の血小板活性化のインビボの役割を決定する.
主な方法:
- PAR4欠乏したマウスを用いて,血小板機能を評価した.
- 評価された血小板の形状の変化,カルシウム動員,ATPの分泌,およびトロンビンに対する反応として集積.
- 動脈動脈血栓症のモデルで評価された出血時間と保護.
主要な成果:
- PAR4欠乏したマウスの血小板は,形状変化,カルシウム動員,ATP分泌,または集積を含む,トロンビンに対する反応を示さなかった.
- PAR4シグナリングは,マウスにおけるトロンビン誘発の血小板活性化に必要であることが示されています.
- PAR4欠乏したマウスは,出血時間が著しく延長され,動脈動脈血栓症から保護された.
結論:
- PAR4シグナル伝達によるトロンビン媒介の血小板活性化は,正常な血液静止には不可欠である.
- トロンビン誘発の血小板活性化をターゲットにすることは,血栓症の治療に有効な治療戦略である可能性があります.
関連する概念動画
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
Formation of the Platelet Plug
8.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.7K
Extrinsic and Intrinsic Pathways of Hemostasis
12.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
12.0K
Clot Retraction and Fibrinolysis
8.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.4K
Introduction to Hemostasis
13.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.3K
Structure and Function of Platelets
2.9K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.9K


